Difo Network

2gether is developing the bank of the future, a future where; consumers take full ownership and control of the services they use, move beyond solely interacting with euros and dollars and fully embrace cryptocurrencies and digital assets, and augment their financial decisions through the use of exponential technologies like artificial intelligence, big data and blockchain. We are on a mission to change the way people interact with their finances. We are building a modern mutual organisation where everyone is an owner of their banking experience.

Aimedis is an AI backed, blockchain and smart contract supported medical ecosystem, that changes the way patients, doctors, and hospitals communicate, connect and handle information. Using the Aimedis platform, users can store, secure and share their medical information only with the people they want to share it with by using the Aimedis right management system. Beside the records, AImedis offers videochat and communication with other patients and doctors, online prescriptions, online appointments, learning content, the inclusion of fitness trackers and devices like ECG or bloodpressure monitors into the system, while all transactions inside the system are backed by our porprietary private AIMChain blockchain, while the token is bound to a public blockchain (Aimedis dual-blockchain model). AIMSocial will be the new incentivised and decentralized medical social network where patients can help other patients and get rewarded for it, while the system is supported by AI.

Verity makes it easy for people to get paid for reporting on real-time events and information around them, while developers can get any data they want in a cheap, fast and secure data feed. It uses sub-ms network to process data with wisdom of the crowd approach and uses blockchain‑as‑a‑court‑system on Ethereum network to guarantee security and fairness.

Cure WorldCosplay is the world’s largest Cosplay platform, supporting 12 languages where more than 720,000 members from more than 180 countries post their quality works - 6.5 million images and counting. Our official social media accounts are followed by more than 430,000 people across Facebook, Twitter, and Weibo. We have a strong emphasis on providing community service which is characterized by self-sustainability and development. Cosplayers have various motivations for their activity, some Cosplayer want to become professional, others want more fans, and yet others are looking to share their work with groups. Photographers and Props Makers working closely with Cosplayers also have some influence on the increasing diversity of motivations. COT will be used as a payment currency within the Cure WorldCosplay ecosystem, helping cosplayers without access to other online payment methods to be tipped for their services. Using the Cure Protocol, players will also be able to create and distribute their own personalised coin. This unique feature will bring power back to cosplayers, enabling them to monetize themselves as these coins can be used to tip players as well as purchase merchandise or event tickets. Player Coins will provide an accessible platform for cosplayers to promote their identity to the continuously growing 720,000 member-base of Cure WorldCosplay, as they will be directly attainable by fans. These coins will also allow cosplayers to develop deeper relationships with their communities, as users will be able to explicitly show their support while also gamifying their experience.

Agate is the world's most comprehensive decentralized blockchain platform for instant payment without volatility risk to mainstream crypto adoption.

MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.